Medical News

RSS

Researchers to measure children with Down syndrome to develop new growth charts

Parents and doctors have known for a long time that children with Down syndrome tend to grow more slowly and are considerably shorter than most other children. But pediatricians needing to record growth milestones at regular office visits have an outdated set of growth charts based on data collected more than 25 years ago.

23 Apr 2010

Poll: Americans confused about new health law

USA Today: "More than half of the nation is confused about President Obama's recently enacted health care law and 56% of Americans say they don't have enough information to understand how the measure will affect them, according to a poll released today by the nonpartisan Kaiser Family Foundation."

23 Apr 2010

Medical Properties Trust closes underwritten public offering of common stock

Medical Properties Trust, Inc. announced today that it closed the sale of its previously announced underwritten public offering of shares of common stock, which included 26 million shares of common stock issued on April 20, 2010 and 3.9 million shares of common stock issued on April 22, 2010 pursuant to the exercise in full of the underwriters' over-allotment option.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

Mayo Clinic study finds changes in tissue damage throughout the course of MS

A new Mayo Clinic study has found that the type of tissue damage changes throughout the course of multiple sclerosis. In early relapsing disease stages, the plaques, or areas where the nervous system is inflamed or demyelinated, are predominantly active with distinct heterogeneous patterns of myelin damage.

23 Apr 2010

Interdisciplinary research leads to first known use of smart nanofilm on living tissue

Louisiana Tech students Mridhula Thangaraj and Chris Monceaux will participate in a symposium on 'Regenerative Medicine - Wound Healing' at the 2010 Experimental Biology meeting, April 24-28 at the Anaheim Convention Center.

23 Apr 2010

Deadly fungus on the move

Researchers revealed this Thursday that a deadly fungus that is usually found only in the tropics is making its way to the Pacific Coast of British Columbia and south into Washington, Oregon and Idaho.

23 Apr 2010

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.

23 Apr 2010

COSMOS project launched to investigate link between use of mobile phones and health problems

A new decades-long study launches today to investigate whether there is a link between the use of mobile phones and long-term health problems such as cancer.

23 Apr 2010

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Affymax, Inc. today announced that it has instituted a quiet period to curtail discussions with the investor community and the media in connection with the analysis of Phase 3 results for the investigational drug, Hematide, in four clinical trials (PEARL 1, PEARL 2, EMERALD 1 and EMERALD 2) which evaluated Hematide for the treatment of anemia in chronic renal failure patients.

23 Apr 2010

CSL Biotherapies comments on influenza vaccine paediatric adverse events

CSL Biotherapies is aware of reports of a number of adverse events following influenza vaccination of children. CSL is one of several suppliers of influenza vaccine in Australia.

23 Apr 2010

Investigators raid N.Y. Senate official's office, seeking evidence in Medicare, Medicaid fraud lawsuit

Federal and state investigators raided the Bronx offices of the Soundview HealthCare Network early Wednesday, seeking records as part of a joint investigation into the business and political activities of the Senate majority leader, Pedro Espada, Jr. More than a dozen agents from the Federal Bureau of Investigation and the Internal Revenue Service, joined by investigators from the office of Attorney General Andrew M. Cuomo, arrived at Soundview's offices on White Plains Road shortly before 7 a.m., when the first employees arrived to open the doors for the day.

23 Apr 2010

Researchers use electronic medical records for injury management and surveillance during marathon

Henry Ford Hospital researchers have brought the use of electronic medical records out of the hospital setting and into the streets by using the technology for a marathon.

23 Apr 2010

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

23 Apr 2010

SVS publishes first supplement on diversity articles to Journal of Vascular Surgery

The Society for Vascular Surgery published its first supplement on diversity articles to its Journal of Vascular Surgery in April 2010.

23 Apr 2010

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted it patent number GB2460597 titled "N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2 RECEPTORS."

23 Apr 2010

isrp awarded $16M grant to study health effects of environmental pollutants

The National Institute of Environmental Health Sciences has awarded the University of Iowa Superfund Research Program (isrp) a five-year, $16 million grant to study the health effects of environmental pollutants, especially polychlorinated biphenyls (PCBs) found in water, former industrial sites and the atmosphere.

23 Apr 2010

Complaint regarding Dragon Pharma's proposed merger with Datong Investment filed

Dragon Pharmaceutical Inc. announced today that a complaint regarding its proposed merger with Datong Investment Inc was filed in the Circuit Court of the Fifteenth Judicial Circuit for Palm Beach County, State of Florida, against the Company, and its eight directors.

23 Apr 2010

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

In the battle against cancer and other diseases, precise analysis of specific proteins can point the way toward targeted treatments. Scientists at theTechnische Universitaet Muenchen, together with Fujitsu Laboratories of Japan, have developed a novel biosensor chip that not only recognizes proteins that are characteristic for specific diseases, but also can show if these proteins are changed through the influence of disease or drugs.

23 Apr 2010

Medical News

Researchers to measure children with Down syndrome to develop new growth charts

Poll: Americans confused about new health law

Medical Properties Trust closes underwritten public offering of common stock

Nile Therapeutics prices underwritten public offering of common stock

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Mayo Clinic study finds changes in tissue damage throughout the course of MS

Interdisciplinary research leads to first known use of smart nanofilm on living tissue

Deadly fungus on the move

Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman Memorial Award

COSMOS project launched to investigate link between use of mobile phones and health problems

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

CSL Biotherapies comments on influenza vaccine paediatric adverse events

Investigators raid N.Y. Senate official's office, seeking evidence in Medicare, Medicaid fraud lawsuit

Researchers use electronic medical records for injury management and surveillance during marathon

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

SVS publishes first supplement on diversity articles to Journal of Vascular Surgery

Amira Pharmaceuticals granted UK patent covering novel small molecule inhibitors of DP2 receptor

isrp awarded $16M grant to study health effects of environmental pollutants

Complaint regarding Dragon Pharma's proposed merger with Datong Investment filed

TUM scientists collaborate with Fujitsu Laboratories of Japan to commercialize biosensor chip

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News